166 related articles for article (PubMed ID: 31764519)
61. Neuropsychiatric systemic lupus erythematosus in a girl with neurocutaneous melanosis caused by a somatic mutation in NRAS.
Inoguchi T; Takenouchi T; Yamazaki F; Kondo Y; Mitamura H; Kosaki K; Takahashi T
Rheumatology (Oxford); 2022 Aug; 61(8):e224-e226. PubMed ID: 35238342
[No Abstract] [Full Text] [Related]
62. [Neurocutaneous melanosis--a case report].
Yoshioka S; Miyayama H; Ishihara A; Kochi M; Ushio Y
No To Shinkei; 1994 Mar; 46(3):279-84. PubMed ID: 8192943
[TBL] [Abstract][Full Text] [Related]
63. Role of positron emission tomography in the management of neurocutaneous melanocytosis.
Cabanillas M; Ginarte M; Monteagudo B; Toribio J
Pediatr Dermatol; 2009; 26(3):351-2. PubMed ID: 19706106
[TBL] [Abstract][Full Text] [Related]
64. Neurocutaneous melanosis: an atypical presentation.
Khera S; Sarkar R; Jain RK; Saxena AK
J Dermatol; 2005 Jul; 32(7):602-5. PubMed ID: 16335879
[TBL] [Abstract][Full Text] [Related]
65. [Congenital neurocutaneous melanosis].
Luo LK; Teng LH; Zhao J; Zhou SY; Xu WX; Li JM
Zhonghua Bing Li Xue Za Zhi; 2005 Apr; 34(4):246-7. PubMed ID: 16091184
[No Abstract] [Full Text] [Related]
66. Neurocutaneous melanosis.
Burstein F; Seier H; Hudgins PA; Zapiach L
J Craniofac Surg; 2005 Sep; 16(5):874-6. PubMed ID: 16192875
[TBL] [Abstract][Full Text] [Related]
67. The pathologic features of neurocutaneous melanosis in a cynomolgus macaque.
Chen Y; Deng W; Zhu H; Li J; Xu Y; Dai X; Jia C; Kong Q; Huang L; Liu Y; Ma C; Xiao C; Liu Y; Li Q; Bezard E; Qin C
Vet Pathol; 2009 Jul; 46(4):773-5. PubMed ID: 19276048
[TBL] [Abstract][Full Text] [Related]
68. Neurocutaneous melanocytosis.
Flores-Sarnat L
Handb Clin Neurol; 2013; 111():369-88. PubMed ID: 23622187
[TBL] [Abstract][Full Text] [Related]
69. Rare presentation in an adult patient with neurocutaneous melanosis.
Ge P; Wang H; Zhong Y; Chen B; Ling F; Luo Y
Int J Dermatol; 2010 Nov; 49(11):1311-3. PubMed ID: 20964655
[No Abstract] [Full Text] [Related]
70. Aggressive melanoma in an infant with congenital melanocytic nevus syndrome and multiple, NRAS and BRAF mutation-negative nodules.
de la Rosa Carrillo D; Vindenes H; Kinsler VA; Rønnestad A; Ringstad G; Müller LO; Tafjord S; Tønseth KA; Kvamme B; Clausen OPF
Pediatr Dermatol; 2018 Sep; 35(5):e281-e285. PubMed ID: 29999207
[TBL] [Abstract][Full Text] [Related]
71. Progressive brainstem compression in an infant with neurocutaneous melanosis and Dandy-Walker complex following ventriculoperitoneal shunt placement for hydrocephalus. Case report.
McClelland S; Charnas LR; SantaCruz KS; Garner HP; Lam CH
J Neurosurg; 2007 Dec; 107(6 Suppl):500-3. PubMed ID: 18154021
[TBL] [Abstract][Full Text] [Related]
72. Copy number abnormalities in new or progressive 'neurocutaneous melanosis' confirm it to be primary CNS melanoma.
Kinsler VA; Polubothu S; Calonje JE; Chong WK; Thompson D; Jacques TS; Morrogh D
Acta Neuropathol; 2017 Feb; 133(2):329-331. PubMed ID: 27933403
[No Abstract] [Full Text] [Related]
73. Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies.
Price HN; Schaffer JV
Clin Dermatol; 2010; 28(3):293-302. PubMed ID: 20541682
[TBL] [Abstract][Full Text] [Related]
74. Rapidly progressive and fatal neurocutaneous melanosis presenting as recurrent headache.
Yamazaki Y; Matsuzawa T; Takasugi K; Suzuki N; Kanda M; Kobayashi I
Pediatr Int; 2013 Apr; 55(2):240-3. PubMed ID: 23679165
[TBL] [Abstract][Full Text] [Related]
75. Giant congenital melanocytic nevi: brain magnetic resonance findings in neurologically asymptomatic children.
Frieden IJ; Williams ML; Barkovich AJ
J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):423-9. PubMed ID: 8077466
[TBL] [Abstract][Full Text] [Related]
76. NRAS(Q61K) mutated primary leptomeningeal melanoma in a child: case presentation and discussion on clinical and diagnostic implications.
Angelino G; De Pasquale MD; De Sio L; Serra A; Massimi L; De Vito R; Marrazzo A; Lancella L; Carai A; Antonelli M; Giangaspero F; Gessi M; Menchini L; Scarciolla L; Longo D; Mastronuzzi A
BMC Cancer; 2016 Jul; 16():512. PubMed ID: 27439913
[TBL] [Abstract][Full Text] [Related]
77. The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis.
Basu D; Salgado CM; Bauer B; Khakoo Y; Patel JR; Hoehl RM; Bertolini DM; Zabec J; Brzozowski MR; Reyes-Múgica M
Cancer Genomics Proteomics; 2018; 15(4):239-248. PubMed ID: 29976629
[TBL] [Abstract][Full Text] [Related]
78. Coexisting intracranial meningeal melanocytoma, dermoid tumor, and Dandy-Walker cyst in a patient with neurocutaneous melanosis. Case report.
Kang SG; Yoo DS; Cho KS; Kim DS; Chang ED; Huh PW; Kim MC
J Neurosurg; 2006 Mar; 104(3):444-7. PubMed ID: 16572661
[TBL] [Abstract][Full Text] [Related]
79. Neurocutaneous Melanosis in Association With Large Congenital Melanocytic Nevi in Children: A Report of 2 Cases With Clinical, Radiological, and Pathogenetic Evaluation.
Chen L; Zhai L; Al-Kzayer LFY; Sarsam SN; Liu T; Alzakar RH; Nakazawa Y
Front Neurol; 2019; 10():79. PubMed ID: 30792691
[No Abstract] [Full Text] [Related]
80. [Melanocytic meningitis and large congenital melanocytic naevus: neurocutaneous melanosis].
Feuillet L; Kaphan E; Audoin B; Witjas T; Pelletier J; Pellissier JF; Ali Cherif A
Rev Neurol (Paris); 2003 Apr; 159(4):435-9. PubMed ID: 12773873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
